What Percentage of Americans Have Never Had COVID?

Key Context on COVID-19 Infection Rates in the United States

As the COVID-19 pandemic has evolved, understanding how many Americans have never been infected has become important for public health planning, vaccine and treatment strategies, and individual risk assessment. This article explains what available data show about the share of U.S. residents who report no prior infection, how estimates differ across studies and time periods, and what factors influence these numbers. Because immunity from infection, vaccination, and prior infection wanes, these statistics represent a snapshot that changes with each wave and variant.

National Estimates: What the Data Show

Large national seroprevalence studies—measuring antibodies produced in response to SARS-CoV-2 infection—have consistently found that a majority of Americans have evidence of past infection. The U.S. Centers for Disease Control and Prevention (CDC) has conducted several such surveys since 2021. Based on combined data from its 2021 and 2022 seroprevalence studies, the CDC estimated that approximately 94% of the U.S. population had detectable antibodies indicating previous infection or vaccination by mid-2022, with roughly 66% having infection-derived antibodies alone. More recent seroprevalence analyses through 2023 and 2024 suggest that, by the end of 2023, roughly 95% or more of U.S. adults had evidence of prior SARS-CoV-2 infection or vaccination, and closer to 90% had infection-induced antibodies.

Using these figures, reliable estimates suggest that fewer than 5% of U.S. adults have never been infected. Among children, the share without prior infection is higher, but even there, cumulative infection rates remain substantial as waves have progressed. In practical terms, this means most Americans have either experienced COVID-19, been vaccinated, or both, and that the proportion with no infection history is small and declining over time.

Reported COVID-19 Infection Status Among U.S. Adults (Seroprevalence Snapshot)

Self-Reported Versus Infection-Based Estimates

Two main sources inform our understanding of the share who have never had COVID-19: self-reported survey data and seroprevalence (antibody) studies. Self-reported figures, such as those from the U.S. National Health Interview Survey (NHIS), typically show a higher share saying they have never tested positive. This gap occurs because not everyone with prior infection has detectable antibodies, people may forget or misremember infections, and not all infections are confirmed with a test. Seroprevalence studies, which measure antibodies produced by the body after infection, provide a more direct, though imperfect, indicator of past infection and are generally considered more reliable for estimating cumulative infection rates.

Comparison Snapshot: Self-Report vs Antibody Evidence

• Self-reported never infected (NHIS): Approximately 35–40% of U.S. adults
• Estimated never infected by seroprevalence: Under 5% of U.S. adults
• Key reason for difference: Prior asymptomatic or unreported infections and timing of antibody measurement

How Vaccination and Waning Immunity Shape the Picture

Vaccination adds another layer to population immunity. Many people who have never been infected have nonetheless received one or more vaccine doses, meaning they are protected without a prior infection history. As immunity wanes and new variants circulate, some previously infected individuals may again test positive—especially if many months have passed since their last infection or booster. At the same time, behavioral changes, masking during peaks, and hybrid immunity (infection plus vaccination) have altered infection risks for different subgroups, which in turn affects the proportion with no infection history over time.

Demographic and Geographic Variation

Statistical averages mask meaningful differences across age, occupation, and community setting. Older adults who were eligible for vaccination earlier generally have higher cumulative infection rates than younger cohorts, but this pattern shifts as schools and younger groups experience more waves. Household composition, urban density, and occupational exposure (e.g., health care, education, transportation) also correlate with infection risk. Consequently, the share who have never had COVID-19 can vary noticeably by region, reflecting differences in outbreak timing, public health measures, and local vaccination coverage.

What This Means for Individual Risk and Public Health

Small changes in the overall share never infected matter less for population-level risk than the characteristics of circulating variants, vaccination coverage, and health system capacity. Being uninfected does not equate to zero risk, because future exposure can still lead to infection; likewise, prior infection provides variable and waning protection. For individuals, the relevant questions are current vaccine and booster status, local transmission levels, and personal risk factors. For planners, trends in infection-naive populations can help anticipate demand for treatments, vaccination outreach, and supportive measures during future surges.

Limitations and Data Gaps

Estimates of the share who have never had COVID-19 depend on testing access, timing of surveys, and definitions of prior infection. Seroprevalence studies typically capture only recent or moderately distant past infections depending on the antibody markers measured and can underrepresent infections with low antibody response. Self-reported data are subject to recall bias and may not reflect asymptomatic or untested cases. Additionally, demographic groups with less access to testing or health care may be underrepresented, which can affect the accuracy of national estimates. As new variants and immunity patterns emerge, periodic recalibration of seroprevalence and infection histories is necessary.

Bottom Line

Most Americans now have evidence of SARS-CoV-2 infection or vaccination, so the share who have never had COVID-19 is small—estimates from seroprevalence studies place it under 5% among adults—with self-reported figures suggesting a higher but still sizable minority. Infection patterns vary by age, community, and occupation, and these statistics evolve with each wave and immunity-building intervention. For individuals, current protection depends on the interplay of prior infection, up-to-date vaccination, and local transmission. Understanding these dynamics offers clarity without guaranteeing future outcomes, reinforcing the value of layered prevention rather than reliance on infection history alone.